{
    "question": "Based on the provided evidence, answer the following question: Who was Danny R Youlden's employer before 2015?. If the evidence is insufficient to answer the question, return 'INSUFFICIENT_INFORMATION'.",
    "content": {
        "source_1": "Title: The Unwavering Commitment of Danny R Youlden: A Cancer Research Legacy\n\nIn the sun-kissed state of Queensland, Australia, a quiet revolution was brewing in the fight against cancer. Behind the scenes, a dedicated researcher, Danny R Youlden, was tirelessly working to unravel the mysteries of this devastating disease. For years, Youlden's name was synonymous with excellence in cancer research, and his affiliation with Cancer Council Queensland was a testament to his unwavering commitment to the cause. The year was 2005 when Youlden joined the esteemed Cancer Council Queensland, an organization dedicated to reducing the impact of cancer on individuals and families across the state. As a researcher, Youlden was drawn to the council's mission to fund life-changing research, provide support services, and advocate for cancer prevention and early detection. His expertise in epidemiology and biostatistics made him an invaluable asset to the team. One of Youlden's most significant contributions during his tenure at Cancer Council Queensland was his work on the Queensland Cancer Registry. This comprehensive database, established in 1982, aimed to collect and analyze data on all cancer cases diagnosed in Queensland. Youlden's meticulous attention to detail and statistical prowess enabled him to extract valuable insights from the registry, shedding light on cancer trends, patterns, and outcomes in the state. A seminal study published in 2011, co-authored by Youlden, demonstrated the significance of the Queensland Cancer Registry in informing cancer control strategies. The research, which analyzed data from 1982 to 2007, revealed a decline in cancer mortality rates in Queensland, attributed to improved screening, diagnosis, and treatment options. This groundbreaking study not only underscored the importance of cancer registries but also highlighted Youlden's expertise in extracting meaningful conclusions from complex data sets. Youlden's collaboration with Cancer Council Queensland also extended to the development of evidence-based cancer prevention programs. His research on the impact of lifestyle factors, such as physical activity and diet, on cancer risk informed the council's public health campaigns. One such initiative, the \"Get Active, Feel Good\" program, encouraged Queenslanders to adopt healthy habits to reduce their cancer risk. Youlden's scientific input ensured that the program was grounded in empirical evidence, increasing its effectiveness in promoting behavioral change. Throughout his career, Youlden's work was characterized by a relentless pursuit of excellence and a passion for improving cancer outcomes.",
        "source_2": "In the year 2043, the world was on the cusp of a medical revolution. Advances in technology and artificial intelligence had transformed the field of medicine, allowing for unprecedented breakthroughs in disease treatment and prevention. At the forefront of this revolution was the UCLA David Geffen School of Medicine, a prestigious institution that had long been a hub for innovation and discovery. On a typical Tuesday morning, February 5th, 2043, the campus was buzzing with activity. Researchers and students hurried to and fro, exchanging ideas and collaborating on projects that would change the face of healthcare. Among them was Danny R Youlden, a brilliant and dedicated researcher who had made the UCLA David Geffen School of Medicine his professional home. As Danny walked into the state-of-the-art laboratory, he was greeted by the soft hum of machinery and the faint glow of holographic displays. His team was already assembled, sipping coffee and reviewing the day's agenda on their augmented reality glasses. Danny took a deep breath, feeling the weight of responsibility on his shoulders. Today was a critical day – they were on the verge of a major breakthrough in their research on regenerative medicine. The team had been working tirelessly for months, pouring over data and running simulations to perfect their technique. Danny's expertise in bioengineering had been instrumental in developing a novel approach to tissue regeneration, one that held the promise of revolutionizing the treatment of degenerative diseases. As they began their experiment, the lab was filled with an air of anticipation. Danny's team worked with precision, each member performing their role with ease. The machines whirred to life, and the room was bathed in a soft blue light as the experiment commenced. Hours passed, and the tension mounted. Danny's team monitored the results, their eyes fixed on the holographic displays as the data began to roll in. And then, suddenly, it happened – the breakthrough they had been working towards for so long. The room erupted in cheers and applause as Danny's team celebrated their triumph. They had done it – they had cracked the code to regenerative medicine. The implications were staggering – this discovery had the potential to change the lives of millions, to eradicate diseases that had plagued humanity for centuries. As Danny smiled, basking in the glow of their achievement, he knew that this was only the beginning. The future was bright, and he was proud to be a part of it."
    },
    "answer": "Cancer Council Queensland"
}